Effect of Kangai No.2 prescription on immune system of patients with advanced colorectal cancer: a randomized controlled study

Shanghai Municipal Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Patients with stage IV colorectal cancer with definite pathological diagnosis;
•(2) Patients aged between 18 and 80 years old;
•(3) There were no serious virus and bacterial infection, no organ failure and serious heart disease;
•(4) There were no other serious complications;
•(5) I agreed to participate in the study and signed the informed consent form after being informed, and the compliance was good.
•(6) There was no allergic reaction to the compatible ingredients in the prescription.

•(1) Patients who are receiving other drug intervention treatment (including other Chinese herbal pieces, chemotherapy, targeted drugs);
•(2) Patients with mental illness themselves, those with lack of autonomous behavior ability, and those with mental disorders have no independent behavior ability;
•(3) Pregnant, ready for pregnancy or lactation.
•(4) Combined with heart, lung, brain, liver, kidney and hematopoietic system and other serious diseases, mental patients.
•(5) Allergic constitution or known allergy to the components of the drug.
•(6) Patients who are participating in other clinical trials or have participated in other clinical trials within 3 months.
•(7) Alcoholism and / or psychoactive substances, drug abusers and addicts.

发起方